THE EFFECTS OF AN ANTACID OR CIMETIDINE ON THE SERUM CONCENTRATIONS OF AZITHROMYCIN

被引:15
作者
FOULDS, G
HILLIGOSS, DM
HENRY, EB
GERBER, N
机构
[1] Central Research Division, of Pfizer, Inc., Groton, Connecticut
[2] Department of Pharmacology, Ohio State University, Columbus, Ohio
关键词
D O I
10.1002/j.1552-4604.1991.tb03701.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of an antacid and of cimetidine on the serum concentrations of azithromycin were examined in volunteers. Ten subjects were given 500 mg azithromycin alone and immediately after being given 30 mL Maalox (Rorer, Fort Washington, PA) in a crossover design. There were no statistically significant differences in T(max) or AUC0-48 after administration of azithromycin alone or with antacid, but mean values of C(max) were reduced by 24% (P = .015). Thus, although C(max) was decreased, the extent of absorption of azithromycin was not affected by coadministration with an antacid. Two groups of six volunteers were given 500 mg azithromycin on day 1. On day 8, one group was given 800 mg cimetidine 2 hours before a dose of azithromycin; the remaining group received placebo before azithromycin. There were no differences in the pharmacokinetic parameters produced by administration with cimetidine or placebo, relative to those on day 1. Thus, cimetidine administered 2 hours before a dose of azithromycin had no apparent effect on the serum concentrations of azithromycin.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 17 条
[1]   INVITRO ACTIVITY OF ERYTHROMYCIN, ROXITHROMYCIN AND CP-62993 AGAINST COMMON PEDIATRIC PATHOGENS [J].
ARONOFF, SC ;
LAURENT, C ;
JACOBS, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (02) :275-276
[2]   INVITRO ACTIVITIES OF AZITHROMYCIN (CP-62,993), CLARITHROMYCIN (A-56268-TE-031), ERYTHROMYCIN, ROXITHROMYCIN, AND CLINDAMYCIN [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :752-754
[3]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[4]   THE INVITRO ACTIVITY OF CP-62,993 AGAINST HEMOPHILUS-INFLUENZAE, BRANHAMELLA-CATARRHALIS, STAPHYLOCOCCI AND STREPTOCOCCI [J].
DUNKIN, KT ;
JONES, S ;
HOWARD, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (04) :405-411
[5]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82
[6]   CYTOLOGICAL EVIDENCE FOR AN INACTIVE X-CHROMOSOME IN MURINE OOGONIA [J].
GARTLER, SM ;
RIVEST, M ;
COLE, RE .
CYTOGENETICS AND CELL GENETICS, 1980, 28 (03) :203-207
[7]   CORRELATION OF THE EXTRAVASCULAR PHARMACOKINETICS OF AZITHROMYCIN WITH INVIVO EFFICACY IN MODELS OF LOCALIZED INFECTION [J].
GIRARD, AE ;
GIRARD, D ;
RETSEMA, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :61-71
[8]   PHARMACOKINETIC AND INVIVO STUDIES WITH AZITHROMYCIN (CP-62,993), A NEW MACROLIDE WITH AN EXTENDED HALF-LIFE AND EXCELLENT TISSUE DISTRIBUTION [J].
GIRARD, AE ;
GIRARD, D ;
ENGLISH, AR ;
GOOTZ, TD ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
HASKELL, SL ;
RETSEMA, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1948-1954
[9]  
GIRARD D, 1990, 6TH INT C INF DIS MO, P77
[10]   INHIBITION OF NORFLOXACIN ABSORPTION BY ANTACIDS [J].
NIX, DE ;
WILTON, JH ;
RONALD, B ;
DISTLERATH, L ;
WILLIAMS, VC ;
NORMAN, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :432-435